CARTO 3 System (Software Version V7.1.80), CARTO VISITAG Module - Product Usage: FGThe intended use of the system is catheter-based cardiac electrophysiological (EP) procedures. The system provides information about the electrical activity of the heart and about catheter location during the procedure. The system can be used on patients who are eligible for a conventional electrophysiological procedure, Product Number: -5400-00, UDI: 10846835000870
Published September 2, 2020 · Recall initiated: June 22, 2020
Summary
FDA records medical device Class II recall Z-2880-2020, published September 2, 2020 and initiated June 22, 2020. Recalling firm: Biosense Webster (israel), Ltd.; Status: Terminated; Reported quantity: N/A; Lot: All serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Software defect may result in disapperance of tag sites during recalculation and lead to additional ablation sites. This may lead to prolongation of the procedure and, in extremely rare circumstances, cardiac perforation.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biosense Webster (israel), Ltd.
- Distributor
- Worldwide distribution - US Nationwide distribution including in the states of AL, AK, AZ, AR, CA, CO, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WV, and WI *Three (3) U.S. government consignees. The countries of Australia, Austria, Belgium, Chile, China, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Latvia, Netherlands, Norway, Poland, Portugal, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, United Kingdom.
- Lot
- All serial numbers
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Israel
Related recalls
- FDAVITROS XT7600 Integrated System, Product code 6844461September 2, 2020
- FDACios Spin, Image-Intensified Fluoroscopic X-Ray System The Cios Alpha and Cios Spin are a mobile X-Ray systemSeptember 2, 2020
- FDAVITROS XT3400 Chemistry System, Product code 6844458September 2, 2020
- FDAFlexible Intubation Fiberscope, Part: 11301AA1, with Instruction Manual: Z18441US - Product Usage: areSeptember 2, 2020
- FDAVITROS XT Chemistry Products TBIL-ALKP Slides (ALKP is not affected) In Vitro Diagnostic use only - The TBILSeptember 2, 2020
- FDAFlexible Intubation Fiberscope, Part: 11301BN1, with Instruction Manual: Z18441US - Product Usage: areSeptember 2, 2020
Questions about this recall
Was CARTO 3 System (Software Version V7.1.80), CARTO VISITAG Module - Product Usage: FGThe intended use of the system is catheter-based cardiac electrophysiological (EP) procedures. The system provides information about the electrical activity of the heart and about catheter location during the procedure. The system can be used on patients who are eligible for a conventional electrophysiological procedure, Product Number: -5400-00, UDI: 10846835000870 recalled?
Yes. FDA published recall Z-2880-2020 on September 2, 2020. Reported hazard: Software defect may result in disapperance of tag sites during recalculation and lead to additional ablation sites. This may lead to prolongation of the procedure and, in extremely rare circumstances, cardiac perforation.
What should I do if I have this product?
Voluntary: Firm initiated · Letter